LSTA - LISATA THERAPEUTICS, INC.

QQQ $ 612.22 $ -10.09 (-1.62 %)

DIA $ 469.75 $ -2.78 (-0.59 %)

SPY $ 671.14 $ -6.30 (-0.93 %)

TLT $ 89.79 $ 0.21 (0.23 %)

GLD $ 366.14 $ -1.11 (-0.3 %)

Previous Close

$ 2.34

Open

$ 2.19

Bid

$ 2.21 x 1

Ask

$ 2.35 x 116

Day's Range

$ 2.17 - $ 2.33

52 Week Range

$ 1.87 - $ 4.20

Volume

233,618

Average Volume

Market Cap

20.49M

Beta (5Y Monthly)

$ -2.34

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	02-27-2025	01-01-1970	10-K
4	11-12-2024	09-30-2024	10-Q
5	08-12-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-29-2024	12-31-2023	10-K
8	11-02-2023	09-30-2023	10-Q
9	08-14-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	03-30-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-04-2022	06-30-2022	10-Q
14	05-05-2022	03-31-2022	10-Q
15	03-22-2022	12-31-2021	10-K
16	11-04-2021	09-30-2021	10-Q
17	08-05-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	02-25-2021	12-31-2020	10-K
20	11-05-2020	09-30-2020	10-Q
21	08-13-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	03-05-2020	12-31-2019	10-K
24	11-06-2019	09-30-2019	10-Q
25	08-08-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	03-14-2019	12-31-2018	10-K
28	11-08-2018	09-30-2018	10-Q
29	08-09-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	03-22-2018	12-31-2017	10-K
32	11-09-2017	09-30-2017	10-Q
33	08-10-2017	06-30-2017	10-Q
34	05-15-2017	03-31-2017	10-Q
35	03-17-2017	12-31-2016	10-K
36	11-07-2016	09-30-2016	10-Q
37	08-09-2016	06-30-2016	10-Q
38	05-05-2016	03-31-2016	10-Q
39	03-15-2016	12-31-2015	10-K
40	11-05-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Lisata Therapeutics Q3 EPS $(0.49) Beats $...
11/06/2025 21:10:13

Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.49) per share which beat the analyst consensus estimate of $...

Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

12 Health Care Stocks Moving In Tuesday's ...
11/04/2025 21:06:29

Lisata Therapeutics Releases Preclinical D...
11/04/2025 21:03:24

Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company de...

Lisata Therapeutics And Catalent Enters Gl...
10/08/2025 12:35:45

Lisata Therapeutics Releseass Preliminary ...
09/29/2025 12:06:00

Results to be presented at the AACR Special Conference in Cancer Research: Advances in Pancreatic Cancer Research—Emerging Scie...

HC Wainwright & Co. Reiterates Buy on Lisa...
08/21/2025 11:18:18

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lisata Therapeutics (NASDAQ:LSTA) with a Buy and maintains $15 p...

Lisata Therapeutics Q2 EPS $(0.54) Beats $...
08/07/2025 20:36:05

Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

12 Health Care Stocks Moving In Monday's P...
07/21/2025 12:08:15

Lisata Therapeutics And WARPNINE Announce ...
07/17/2025 12:04:57

Brookline Capital Maintains Buy on Lisata ...
07/15/2025 15:21:58

Brookline Capital maintains Lisata Therapeutics (NASDAQ:LSTA) with a Buy and raises the price target from $20 to $32.

U.S. Patent And Trademark Office Issues Li...
07/15/2025 12:11:13

Newly issued U.S. patent extends certepetide IP protection to 2040, with subsequent opportunity for patent term extensionThis p...

AGITG, NHMRC Clinical Trials Centre At Uni...
06/26/2025 12:07:39

ASCEND comprises two dosing regimens of certepetide evaluated in two separate study arms enrolled sequentiallyPositive signal i...

Lisata Therapeutics And GATC Health Announ...
06/17/2025 12:08:15

Expanded alliance combines Lisata's drug development expertise with GATC's AI-powered Multiomics Advanced Technology® p...

Lisata Therapeutics Q1 EPS $(0.55) Misses ...
05/08/2025 20:09:52

Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

Lisata Enters Into Research License With C...
04/15/2025 12:04:59

BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (NASDAQ:LSTA) ("Lisata" or the "C...

Lisata Therapeutics And GATC Health Begin ...
03/05/2025 13:33:26

Strategic collaboration harnesses GATC's proprietary Artificial Intelligence-powered, validated Multiomics Advanced Technol...

Lisata Therapeutics Q4 GAAP EPS $(0.55) Be...
02/27/2025 21:56:12

Lisata Therapeutics (NASDAQ:LSTA) reported quarterly losses of $(0.55) per share which beat the analyst consensus estimate of $...